Novo Nordisk's gilded stock yields almost USD 59bn over 20 years

88 percent of Novo Nordisk’s net profits over the past three years have gone back to shareholders, reports CFO Karsten Munk Knudsen.
Karsten Munk Knudsen, chief financial officer at Novo Nordisk | Photo: Novo Nordisk / PR
Karsten Munk Knudsen, chief financial officer at Novo Nordisk | Photo: Novo Nordisk / PR
by CHRISTIAN BUNDGAARD, translated by daniel pedersen

As it turns out, shareholders in Novo Nordisk have made a good investment.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading